MedTrace Logo

Mechanisms of Anabolic Osteoporosis Therapy

NCT05688969 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2025-12-18

No results posted yet for this study

Summary

The aim of this study is to investigate the effect of romosozumab on bone cells during early and late phases of treatment.

Conditions

  • Osteoporosis, Postmenopausal

Interventions

OTHER

early versus late biopsy

early (3-6 weeks) versus late (6-8 months) biopsy

Sponsors & Collaborators

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Benjamin Leder, MD · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-14
Primary Completion
2028-02-29
Completion
2028-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05688969 on ClinicalTrials.gov